BPAMU
PFE icon

BTG Pactual Asset Management US’s Pfizer PFE Stock Holding History

BTG Pactual Asset Management US’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,314
Closed -$250K – 316
2025
Q3 		$250K Buy
+10,314
New +$255K 0.01% 165

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BTG Pactual Asset Management US's PFE Position: Q4 2025 in Review

BTG Pactual Asset Management US sold out of Pfizer (PFE) in Q4 2025, closing a stake of 10,314 shares — an estimated $250K sold.

BTG Pactual Asset Management US first reported a position in PFE in Q3 2025 and held it in 1 quarter. The position peaked at $250K in Q3 2025. 2,915 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • BTG Pactual Asset Management US reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • BTG Pactual Asset Management US sold 10,314 Pfizer shares in Q4 2025, an estimated $250K.
  • BTG Pactual Asset Management US first reported a position in Pfizer in Q3 2025 and held it in 1 quarter.
  • BTG Pactual Asset Management US's Pfizer position peaked at $250K in Q3 2025.
  • 2,915 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on BTG Pactual Asset Management US's 13F filing for Q4 2025, filed 17 Feb 2026.